INS and diabetes mellitus: A multicenter, randomized clinical trial compared the effects of transient intensive insulin therapy—continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI)—versus oral antidiabetic agents on beta-cell function and diabetes remission.